Riskpilot← Back to searchSign inGet full accessENGVALL & ENGVALL AB
ABActiveOrg 5591659544Östraby 9031Other human health activities n.e.c. · NACE 8699Est. 20181 employees
Revenue 2024
SEK 72K
-31% vs 2023
EBITDA margin
4.6%
+105% vs 2023
Equity ratio
97.5%
Financial strength
Net profit 2024
SEK 6K
+111% vs 2023
| Revenue | SEK 72K | -31% |
| EBITDA | SEK 3K | +105% |
| Net profit | SEK 6K | +111% |
| Total assets | SEK 120K | -25% |
| Equity | SEK 117K | +6% |
| Employees | 1 | — |
Legal name
ENGVALL & ENGVALL AB
Org number
5591659544
Legal form
Aktiebolag
NACE code
8699 · Other human health activities n.e.c.
Founded
13 juli 2018
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är att bedriva konsult- och kursverksamhet inom yoga, friskvård, personlig utveckling, hälso- och sjukvård, konsultverksamhet inom IT, utveckla mjukvaruprodukter samt äga och förvalta värdepapper och utöva därmed förenlig verksamhet.
Address
Östraby 9031
Email
hej@omniapura.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 433 | 71 | 61 | 104 | 72 |
| Staff expenses | — | — | −37 | −30 | 7 |
| EBITDA | 192 | 5 | −24 | −62 | 3 |
| Depreciation & amort. | −46 | −46 | −19 | — | — |
| EBIT | 146 | −41 | −43 | −62 | 3 |
| Net financials | — | −2 | 50 | 3 | 3 |
| Profit before tax | 110 | −7 | 7 | −59 | 6 |
| Tax | −24 | −0 | −1 | — | — |
| Net profit | 86 | −7 | 5 | −59 | 6 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 901 | 448 | 398 | 160 | 120 |
| Equity | 358 | 351 | 357 | 110 | 117 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 506 | 96 | 41 | 50 | 3 |
| Total debt | 506 | 96 | 41 | 50 | 3 |
EBITDA margin
4.6%
This company
15.8%
Market median
-71% vs market
20202024
Equity ratio
97.5%
This company
38.2%
Market median
+155% vs market
20202024
Return on equity
5.3%
This company
18.4%
Market median
-71% vs market
20202024
Net profit margin
8.7%
This company
8.1%
Market median
+7% vs market
20202024
Asset turnover
0.60×
This company
1.12×
Market median
-46% vs market
20202024
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ENGVALL & ENGVALL AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sofia Marie Ekeroth | Deputy Board Member | 0 companies |
| Malin Karin Sofia Torbjörnsdotter Engvall | Board of Directors | 0 companies |